Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diosmin + Maiguan Fukang Tablets for Knee Osteoarthritis with Effusion
ChiCTR2500111472Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of diosmin and Maiguan Fukang in knee osteoarthritis (OA) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Intra-articular knee effusion volume. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
diosminMaiguan Fukang
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500111472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111472.